Tag Archives: Childhood vaccine may help prevent severe COVID-19

People whose immune systems responded strongly to a measles-mumps-rubella (MMR) vaccine may be less likely to become severely ill if they are infected with the new coronavirus, new data suggests. The MMR II vaccine, manufactured by Merck and licensed in 1979, works by triggering the immune system to produce antibodies. Researchers reported on Friday in mBio that among 50 COVID-19 patients …

Read More »